Workiva (WK) 10-Q 3 Aug 23 2023 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2023	Jul. 28, 2023
Entity Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	001-36773
Entity Registrant Name	WORKIVA INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	47-2509828
Entity Address, Address Line One	2900 University Blvd
Entity Address, City or Town	Ames
Entity Address, State or Province	IA
Entity Address, Postal Zip Code	50010
City Area Code	888
Local Phone Number	275-3125
Title of 12(b) Security	Class A common stock, par value $.001
Trading Symbol	WK
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0001445305
Document Fiscal Period Focus	Q2
Document Fiscal Year Focus	2023
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Class A Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		49,819,028
Class B Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding		3,845,583

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 198,939	$ 240,197
Marketable securities	267,312	190,595
Accounts receivable, net of allowance for doubtful accounts of $796 and $744 at June 30, 2023 and December 31, 2022, respectively	84,272	106,316
Deferred costs	38,471	38,350
Other receivables	5,472	6,674
Prepaid expenses and other	25,419	17,957
Total current assets	619,885	600,089
Property and equipment, net	25,380	27,096
Operating lease right-of-use assets	11,493	13,932
Deferred costs, non-current	30,810	33,682
Goodwill	111,154	109,740
Intangible assets, net	25,643	28,234
Other assets	6,430	6,847
Total assets	830,795	819,620
Current liabilities
Accounts payable	5,312	6,174
Accrued expenses and other current liabilities	91,118	83,999
Deferred revenue	327,365	316,263
Finance lease obligations	518	504
Total current liabilities	424,313	406,940
Convertible senior notes, non-current	340,907	340,257
Deferred revenue, non-current	39,822	38,237
Other long-term liabilities	1,527	1,518
Operating lease liabilities, non-current	9,749	12,102
Finance lease obligations, non-current	14,320	14,583
Total liabilities	830,638	813,637
Stockholders’ equity
Preferred stock, $0.001 par value per share, 100,000,000 shares authorized, no shares issued and outstanding	0	0
Additional paid-in-capital	595,693	537,732
Accumulated deficit	(592,176)	(525,116)
Accumulated other comprehensive loss	(3,414)	(6,686)
Total stockholders’ equity	157	5,983
Total liabilities and stockholders’ equity	830,795	819,620
Class A Common Stock
Stockholders’ equity
Common stock	50	49
Class B Common Stock
Stockholders’ equity
Common stock	$ 4	$ 4

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Allowance for doubtful accounts	$ 796	$ 744
Preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Preferred stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Class A Common Stock
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, share authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, shares issued (in shares)	49,687,878	48,761,804
Common stock, shares outstanding (in shares)	49,687,878	48,761,804
Class B Common Stock
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, share authorized (in shares)	500,000,000	500,000,000
Common stock, shares issued (in shares)	3,845,583	3,890,583
Common stock, shares outstanding (in shares)	3,845,583	3,890,583

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenue
Total revenue	$ 155,022	$ 131,549	$ 305,211	$ 261,223
Cost of revenue
Total cost of revenue	39,504	32,237	78,022	63,110
Gross profit	115,518	99,312	227,189	198,113
Operating expenses
Research and development	42,697	39,177	88,488	75,061
Sales and marketing	71,882	64,219	142,592	120,319
General and administrative	23,627	24,108	65,638	48,102
Total operating expenses	138,206	127,504	296,718	243,482
Loss from operations	(22,688)	(28,192)	(69,529)	(45,369)
Interest income	4,535	605	8,252	885
Interest expense	(1,499)	(1,512)	(3,000)	(3,030)
Other (expense) income, net	(439)	668	(1,379)	503
Loss before provision for income taxes	(20,091)	(28,431)	(65,656)	(47,011)
Provision for income taxes	819	430	1,404	343
Net loss	$ (20,910)	$ (28,861)	$ (67,060)	$ (47,354)
Net loss per common share:
Basic (in dollars per share)	$ (0.39)	$ (0.55)	$ (1.25)	$ (0.90)
Diluted (in dollars per share)	$ (0.39)	$ (0.55)	$ (1.25)	$ (0.90)
Weighted-average common shares outstanding - basic (in shares)	54,009,963	52,850,470	53,850,986	52,724,051
Weighted-average common shares outstanding - diluted (in shares)	54,009,963	52,850,470	53,850,986	52,724,051
Subscription and support
Revenue
Total revenue	$ 136,772	$ 113,353	$ 266,436	$ 220,473
Cost of revenue
Total cost of revenue	25,083	18,915	49,216	37,448
Professional services
Revenue
Total revenue	18,250	18,196	38,775	40,750
Cost of revenue
Total cost of revenue	$ 14,421	$ 13,322	$ 28,806	$ 25,662

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Statement of Comprehensive Income [Abstract]
Net loss	$ (20,910)	$ (28,861)	$ (67,060)	$ (47,354)
Other comprehensive (loss) income
Foreign currency translation adjustment	308	(6,172)	2,009	(6,088)
Unrealized (loss) gain on available-for-sale securities	(316)	(554)	1,263	(2,414)
Other comprehensive (loss) income	(8)	(6,726)	3,272	(8,502)
Comprehensive loss	$ (20,918)	$ (35,587)	$ (63,788)	$ (55,856)

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock (Class A and B)	Additional Paid-in-Capital	Additional Paid-in-Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning of the period (in shares) at Dec. 31, 2021			51,444,000
Beginning of the period at Dec. 31, 2021	$ 72,979	$ (40,299)	$ 51	$ 525,646	$ (58,560)	$ (288)	$ (452,430)	$ 18,261
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	15,309			15,309
Issuance of common stock upon exercise of stock options (in shares)			62,000
Issuance of common stock upon exercise of stock options	825		$ 1	824
Issuance of common stock under employee stock purchase plan (in shares)			53,000
Issuance of common stock under employee stock purchase plan	5,218			5,218
Issuance of restricted stock units (in shares)			545,000
Tax withholding related to net share settlements of stock-based compensation awards (in shares)			(73,000)
Tax withholding related to net share settlements of stock-based compensation awards	(8,570)			(8,570)
Net loss	(18,493)						(18,493)
Other comprehensive (loss) income	(1,776)					(1,776)
End of period (in shares) at Mar. 31, 2022			52,031,000
End of period at Mar. 31, 2022	25,193		$ 52	479,867		(2,064)	(452,662)
Beginning of the period (in shares) at Dec. 31, 2021			51,444,000
Beginning of the period at Dec. 31, 2021	72,979	$ (40,299)	$ 51	525,646	$ (58,560)	(288)	(452,430)	$ 18,261
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(47,354)
Other comprehensive (loss) income	(8,502)
End of period (in shares) at Jun. 30, 2022			52,239,000
End of period at Jun. 30, 2022	7,854		$ 52	498,115		(8,790)	(481,523)
Beginning of the period (in shares) at Mar. 31, 2022			52,031,000
Beginning of the period at Mar. 31, 2022	25,193		$ 52	479,867		(2,064)	(452,662)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	18,447			18,447
Issuance of common stock upon exercise of stock options (in shares)			76,000
Issuance of common stock upon exercise of stock options	1,145			1,145
Issuance of restricted stock units (in shares)			144,000
Tax withholding related to net share settlements of stock-based compensation awards (in shares)			(12,000)
Tax withholding related to net share settlements of stock-based compensation awards	(1,344)			(1,344)
Net loss	(28,861)						(28,861)
Other comprehensive (loss) income	(6,726)					(6,726)
End of period (in shares) at Jun. 30, 2022			52,239,000
End of period at Jun. 30, 2022	7,854		$ 52	498,115		(8,790)	(481,523)
Beginning of the period (in shares) at Dec. 31, 2022			52,652,000
Beginning of the period at Dec. 31, 2022	5,983		$ 53	537,732		(6,686)	(525,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	38,042			38,042
Issuance of common stock upon exercise of stock options (in shares)			102,000
Issuance of common stock upon exercise of stock options	1,457			1,457
Issuance of common stock under employee stock purchase plan (in shares)			107,000
Issuance of common stock under employee stock purchase plan	5,546			5,546
Issuance of restricted stock units (in shares)			449,000
Tax withholding related to net share settlements of stock-based compensation awards (in shares)			(78,000)
Tax withholding related to net share settlements of stock-based compensation awards	(7,228)			(7,228)
Net loss	(46,150)						(46,150)
Other comprehensive (loss) income	3,280					3,280
End of period (in shares) at Mar. 31, 2023			53,232,000
End of period at Mar. 31, 2023	930		$ 53	575,549		(3,406)	(571,266)
Beginning of the period (in shares) at Dec. 31, 2022			52,652,000
Beginning of the period at Dec. 31, 2022	$ 5,983		$ 53	537,732		(6,686)	(525,116)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)	150,046
Net loss	$ (67,060)
Other comprehensive (loss) income	3,272
End of period (in shares) at Jun. 30, 2023			53,533,000
End of period at Jun. 30, 2023	157		$ 54	595,693		(3,414)	(592,176)
Beginning of the period (in shares) at Mar. 31, 2023			53,232,000
Beginning of the period at Mar. 31, 2023	930		$ 53	575,549		(3,406)	(571,266)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation expense	20,610			20,610
Issuance of common stock upon exercise of stock options (in shares)			47,000
Issuance of common stock upon exercise of stock options	747		$ 1	746
Issuance of restricted stock units (in shares)			266,000
Tax withholding related to net share settlements of stock-based compensation awards (in shares)			(12,000)
Tax withholding related to net share settlements of stock-based compensation awards	(1,212)			(1,212)
Net loss	(20,910)						(20,910)
Other comprehensive (loss) income	(8)					(8)
End of period (in shares) at Jun. 30, 2023			53,533,000
End of period at Jun. 30, 2023	$ 157		$ 54	$ 595,693		$ (3,414)	$ (592,176)

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities
Net loss	$ (20,910)	$ (28,861)	$ (67,060)	$ (47,354)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization	2,867	2,725	5,667	4,684
Stock-based compensation expense	20,610	18,447	58,652	33,756
(Recovery of) provision for doubtful accounts	(57)	20	49	(9)
Realized loss on sale of available-for-sale securities, net	147	0	708	0
(Accretion) amortization of premiums and discounts on marketable securities, net	(1,572)	453	(2,600)	1,113
Amortization of issuance costs and debt discount	325	324	650	648
Deferred income tax	7	63	(3)	(148)
Changes in assets and liabilities:
Accounts receivable	(6,886)	(4,844)	22,477	1,737
Deferred costs	1,362	(2,734)	3,132	(1,290)
Operating lease right-of-use asset	1,268	1,307	2,563	2,608
Other receivables	(381)	385	(286)	565
Prepaid expenses and other	(1,705)	(1,591)	(7,437)	(2,723)
Other assets	510	12	436	35
Accounts payable	(1,088)	(2,300)	(881)	2,064
Deferred revenue	21,060	13,192	11,105	13,798
Operating lease liability	(1,207)	(1,302)	(2,379)	(2,644)
Accrued expenses and other liabilities	11,629	13,388	6,749	907
Net cash provided by operating activities	25,979	8,684	31,542	7,747
Cash flows from investing activities
Purchase of property and equipment	(639)	(671)	(837)	(1,203)
Purchase of marketable securities	(51,204)	(23,798)	(177,019)	(57,946)
Sale of marketable securities	21,339	0	65,052	14,981
Maturities of marketable securities	8,000	40,536	39,905	66,786
Acquisitions, net of cash acquired	0	(99,186)	0	(99,186)
Purchase of intangible assets	(40)	(6)	(119)	(46)
Net cash used in investing activities	(22,544)	(83,125)	(73,018)	(76,614)
Cash flows from financing activities
Proceeds from option exercises	747	1,145	2,204	1,970
Taxes paid related to net share settlements of stock-based compensation awards	(1,212)	(1,344)	(8,440)	(9,914)
Proceeds from shares issued in connection with employee stock purchase plan	0	0	5,546	5,218
Principal payments on finance lease obligations	(125)	(446)	(249)	(888)
Net cash used in financing activities	(590)	(645)	(939)	(3,614)
Effect of foreign exchange rates on cash	609	(1,737)	1,157	(1,652)
Net increase (decrease) in cash and cash equivalents	3,454	(76,823)	(41,258)	(74,133)
Cash and cash equivalents at beginning of period	195,485	303,076	240,197	300,386
Cash and cash equivalents at end of period	198,939	226,253	198,939	226,253
Supplemental cash flow disclosure
Cash paid for interest	204	218	2,350	2,383
Cash paid for income taxes, net of refunds	$ 1,198	$ 438	$ 1,521	$ 628

Organization and Significant Ac

Organization and Significant Accounting Policies	6 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Significant Accounting Policies	Organization and Significant Accounting Policies Organization Workiva Inc., a Delaware corporation, and its wholly-owned subsidiaries (the “Company” or “we” or “us”) is on a mission to power transparent reporting for a better world. We believe that consumers, employees, shareholders, and other stakeholders today expect more from business – more action, transparency, and disclosure of financial and non-financial information. We build solutions to meet that demand and streamline processes, connect data and teams, and ensure consistency – all within the Workiva platform, the world’s leading cloud platform for assured integrated reporting. Our operational headquarters are located in Ames, Iowa, with additional offices located in the United States, Europe, the Asia-Pacific region and Canada. Basis of Presentation and Principles of Consolidation The financial information presented in the accompanying unaudited condensed consolidated financial statements has been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The condensed consolidated balance sheet data as of December 31, 2022 was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, consisting primarily of normal recurring accruals, necessary for a fair presentation of our financial position and results of operations. The operating results for the three and six months ended June 30, 2023 are not necessarily indicative of the results expected for the full year ending December 31, 2023. Seasonality affects our revenue, expenses and cash flows from operations. Revenue from professional services has been higher in the first quarter as many of our customers file their 10-K in the first calendar quarter. Our sales and marketing expense also has some degree of seasonality. With the exception of September 2020 and September 2021 when we transitioned to a virtual event, sales and marketing expense has historically been higher in the third quarter due to our annual user conference in September. In addition, the timing of the payments of cash bonuses to employees during the first and fourth calendar quarters may result in some seasonality in operating cash flow. The condensed consolidated financial information should be read in conjunction with “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in this report and the consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022 filed with the SEC on February 21, 2023. The unaudited condensed consolidated financial statements include the accounts of Workiva Inc. and its wholly-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and various other assumptions believed to be reasonable. These estimates include, but are not limited to, the allowance for doubtful accounts, the determination of the relative selling prices of our services, the measurement of material rights, health insurance claims incurred but not yet reported, valuation of available-for-sale marketable securities, useful lives of deferred contract costs, intangible assets and property and equipment, goodwill, income taxes, discount rates used in the valuation of right-of-use assets and lease liabilities, and certain assumptions used in the valuation of equity awards. While these estimates are based on our best knowledge of current events and actions that may affect us in the future, actual results may differ materially from these estimates. Recently Adopted Accounting Pronouncements None. New Accounting Pronouncements Not Yet Adopted None.

Supplemental Consolidated Balan

Supplemental Consolidated Balance Sheet Information	6 Months Ended
	Jun. 30, 2023
Payables and Accruals [Abstract]
Supplemental Consolidated Balance Sheet Information	Supplemental Consolidated Balance Sheet Information Accrued Expenses and Other Current Liabilities Accrued expenses and other current liabilities consisted of the following (in thousands): As of June 30, 2023 As of December 31, 2022 Accrued vacation $ 16,196 $ 12,939 Accrued commissions 8,508 10,841 Accrued bonuses 14,668 5,597 Accrued payroll 4,190 5,318 Estimated health insurance claims 1,939 1,841 Accrued interest 1,455 1,455 ESPP employee contributions 7,075 5,661 Customer deposits 23,431 25,520 Operating lease liabilities 5,073 5,720 Accrued other liabilities 8,583 9,107 $ 91,118 $ 83,999

Cash Equivalents and Marketable

Cash Equivalents and Marketable Securities	6 Months Ended
	Jun. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Cash Equivalents and Marketable Securities	Cash Equivalents and Marketable Securities At June 30, 2023, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 130,774 $ — $ — $ 130,774 Commercial paper 78,820 — — 78,820 U.S. treasury debt securities 53,749 — (353) 53,396 U.S. government agency debt securities 22,088 — (58) 22,030 Corporate debt securities 115,026 23 (961) 114,088 Foreign government debt securities 996 — (18) 978 $ 401,453 $ 23 $ (1,390) $ 400,086 Included in cash and cash equivalents $ 132,774 $ — $ — $ 132,774 Included in marketable securities $ 268,679 $ 23 $ (1,390) $ 267,312 At December 31, 2022, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 182,878 $ — $ — $ 182,878 U.S. treasury debt securities 72,151 1 (899) 71,253 Corporate debt securities 120,081 62 (1,771) 118,372 Foreign government debt securities 993 — (23) 970 $ 376,103 $ 63 $ (2,693) $ 373,473 Included in cash and cash equivalents $ 182,878 $ — $ — $ 182,878 Included in marketable securities $ 193,225 $ 63 $ (2,693) $ 190,595 The contractual maturities of the investments classified as marketable securities are as follows (in thousands): As of June 30, 2023 Due within one year $ 204,212 Due in one to two years 63,100 $ 267,312 The following table presents gross unrealized losses and fair values for those cash equivalents and marketable securities that were in an unrealized loss position as of June 30, 2023, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in thousands): As of June 30, 2023 Less than 12 months 12 months or greater Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury debt securities $ 45,910 $ (291) $ 6,486 $ (62) U.S. government agency debt securities 22,030 (58) — — Corporate debt securities 73,616 (493) 33,255 (468) Foreign government debt securities — — 978 (18) Total $ 141,556 $ (842) $ 40,719 $ (548) We do not believe the unrealized losses represent credit losses based on our evaluation of available evidence as of June 30, 2023, which includes an assessment of whether it is more likely than not we will be required to sell the investment before recovery of the investment's amortized cost basis.

Fair Value Measurements

Fair Value Measurements	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value Measurements	Fair Value Measurements We determine the fair values of our financial instruments based on the fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value assumes that the transaction to sell the asset or transfer the liability occurs in the principal or most advantageous market for the asset or liability and establishes that the fair value of an asset or liability shall be determined based on the assumptions that market participants would use in pricing the asset or liability. The classification of a financial asset or liability within the hierarchy is based upon the lowest level input that is significant to the fair value measurement. The fair value hierarchy prioritizes the inputs into three levels that may be used to measure fair value: Level 1 - Inputs are unadjusted quoted prices in active markets for identical assets or liabilities. Level 2 - Inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 - Inputs are unobservable inputs based on our assumptions. Financial Assets Cash equivalents primarily consist of AAA-rated money market funds with overnight liquidity and no stated maturities. We classified cash equivalents as Level 1 due to the short-term nature of these instruments and measured the fair value based on quoted prices in active markets for identical assets. When available, our marketable securities are valued using quoted prices for identical instruments in active markets. If we are unable to value our marketable securities using quoted prices for identical instruments in active markets, we value our investments using broker reports that utilize quoted market prices for comparable instruments. We validate, on a sample basis, the derived prices provided by the brokers by comparing their assessment of the fair values of our investments against the fair values of the portfolio balances of another third-party professional pricing service. As of June 30, 2023, all of our marketable securities were valued using quoted prices for comparable instruments in active markets and are classified as Level 2. Based on our valuation of our money market funds and marketable securities, we concluded that they are classified in either Level 1 or Level 2, and we have no financial assets measured using Level 3 inputs on a recurring basis. The following table presents information about our assets that are measured at fair value on a recurring basis using the above input categories (in thousands): Fair Value Measurements as of June 30, 2023 Fair Value Measurements as of December 31, 2022 Description Total Level 1 Level 2 Total Level 1 Level 2 Money market funds $ 130,774 $ 130,774 $ — $ 182,878 $ 182,878 $ — Commercial paper 78,820 — 78,820 — — — U.S. treasury debt securities 53,396 — 53,396 71,253 — 71,253 U.S. government agency debt securities 22,030 — 22,030 — — — Corporate debt securities 114,088 — 114,088 118,372 — 118,372 Foreign government debt securities 978 — 978 970 — 970 $ 400,086 $ 130,774 $ 269,312 $ 373,473 $ 182,878 $ 190,595 Included in cash and cash equivalents $ 132,774 $ 182,878 Included in marketable securities $ 267,312 $ 190,595 Convertible Senior Notes As of June 30, 2023, the fair value of our convertible senior notes was $484.7 million. The fair value was determined based on the quoted price of the convertible senior notes in an over-the-counter market on the last trading day of the reporting period and has been classified as Level 2 in the fair value hierarchy. See Note 5 to the condensed consolidated financial statements for more information.

Convertible Senior Notes

Convertible Senior Notes	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Convertible Senior Notes	Convertible Senior NotesIn August 2019, we issued $345.0 million aggregate principal amount of 1.125% convertible senior notes due 2026 in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended, including the exercise in full by the initial purchasers of their option to purchase an additional $45.0 million principal amount (the “Notes”). The Notes were issued pursuant to an indenture and are senior, unsecured obligations of the Company. The Notes bear interest at a fixed rate of 1.125% per annum, payable semi-annually in arrears on February 15 and August 15 of each year, commencing on February 15, 2020. Proceeds from the issuance of the Notes totaled $335.9 million, net of initial purchaser discounts and issuance costs. The initial conversion rate is 12.4756 shares of our common stock per $1,000 principal amount of Notes, which is equivalent to an initial conversion price of approximately $80.16 per share, subject to adjustment upon the occurrence of specified events. Holders of the Notes may convert all or a portion of their Notes prior to the close of business on May 15, 2026, in multiples of $1,000 principal amount, only under the following circumstances: • during any calendar quarter commencing after the calendar quarter ending on September 30, 2019 (and only during such calendar quarter), if the last reported sale price of our Class A common stock, par value $0.001 per share (which we refer to in this offering memorandum as our “Class A common stock”), for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; • during the five consecutive business day period immediately following any ten consecutive trading day period (the “measurement period”) in which the trading price (as defined below) per $1,000 principal amount of Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of our Class A common stock and the conversion rate on each such trading day; • if we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date; or • upon the occurrence of certain specified corporate events as set forth in the indenture. On or after May 16, 2026, holders of the Notes may convert their Notes at any time until the close of business on the second scheduled trading day immediately preceding the maturity date of the Notes. Upon conversion, we will pay or deliver, as the case may be, cash, shares of our Class A common stock or a combination of cash and shares of our Class A common stock, at our election, in the manner and subject to the terms and conditions provided in the indenture. It is our current intent to settle conversions through a combination settlement of cash and shares of our Class A common stock. The Company may redeem for cash all or any portion of the Notes, at its option, on or after August 21, 2023, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides notice of redemption at a redemption price equal to 100% of the principal amount of the Notes to be redeemed, plus any accrued and unpaid interest to, but excluding, the redemption date. During the second quarter of 2023 none of the conversion conditions were met and therefore the Notes are not convertible at the option of the holders. As a result, the Notes were classified as non-current liabilities on the condensed consolidated balance sheet as of June 30, 2023. Interest expense representing the amortization of issuance costs as well as contractual interest expense is amortized to interest expense at an effective interest rate of 1.5% over the term of the notes. As of June 30, 2023 the if-converted value of the Notes exceeded the principal amount by $92.5 million. As of June 30, 2023, the remaining life of the Notes is approximately 3.2 years. The net carrying amount of the Notes was as follows (in thousands): As of June 30, 2023 December 31, 2022 Principal $ 345,000 $ 345,000 Unamortized issuance costs (4,093) (4,743) Net carrying amount $ 340,907 $ 340,257 Interest expense related to the Notes was as follows (in thousands): Three months ended June 30, Six months ended June 30, 2023 2022 2023 2022 Contractual interest expense $ 970 $ 970 $ 1,940 $ 1,940 Amortization of issuance costs 325 324 650 648 Total interest expense $ 1,295 $ 1,294 $ 2,590 $ 2,588

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Litigation From time to time we may become involved in legal proceedings or be subject to claims arising in the ordinary course of our business. We evaluate the development of legal matters on a regular basis and accrue a liability when we believe a loss is probable and the amount can be reasonably estimated. Although the results of litigation and claims cannot be predicted with certainty, we currently believe that the final outcome of any currently pending legal proceedings to which we are a party will not have a material adverse effect on our business, operating results, financial condition or cash flows. Regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

Stock-Based Compensation

Stock-Based Compensation	6 Months Ended
	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation We grant stock-based incentive awards to attract, motivate and retain qualified employees, non-employee directors and consultants, and to align their financial interests with those of our stockholders. We utilize stock-based compensation in the form of restricted stock units, performance restricted stock units, options to purchase Class A common stock and Employee Stock Purchase Plan ("ESPP") purchase rights. Prior to our corporate conversion in December 2014, awards were provided under the 2009 Unit Incentive Plan (“the 2009 Plan”). The 2009 Plan was amended to provide that no further awards will be issued thereunder, and our board of directors and stockholders adopted and approved our 2014 Equity Incentive Plan (“the 2014 Plan” and, together with the 2009 Plan, “the Plans”). Stock-Based Compensation Expense Stock-based compensation expense was recorded in the following cost and expense categories consistent with the respective employee or service provider’s related cash compensation (in thousands): Three months ended June 30, Six months ended June 30, 2023 2022 2023 2022 Cost of revenue Subscription and support $ 1,413 $ 912 $ 2,485 $ 1,702 Professional services 667 593 1,300 1,045 Operating expenses Research and development 4,825 3,148 9,522 5,873 Sales and marketing 6,703 5,646 13,661 9,731 General and administrative 7,002 8,148 31,684 15,405 Total $ 20,610 $ 18,447 $ 58,652 $ 33,756 During the first six months of 2023, we recognized an additional $18.1 million in stock-based compensation pursuant to certain transition agreements with former executives who retired during the period. Stock Options The following table summarizes the option activity under the Plans for the six months ended June 30, 2023: Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (Years) Outstanding at December 31, 2022 1,509,172 $ 14.57 3.2 Granted — — Forfeited (10) 13.60 Expired — — Exercised (150,046) 14.69 Outstanding at June 30, 2023 1,359,116 $ 14.56 2.7 Exercisable at June 30, 2023 1,359,116 $ 14.56 2.7 Restricted Stock Units and Performance Restricted Stock Units The following table summarizes the restricted stock unit and performance restricted stock unit activity under the Plans for the six months ended June 30, 2023: Number of Shares Weighted- Average Grant Date Fair Value Unvested at December 31, 2022 1,921,927 $ 93.80 Granted 996,365 93.10 Forfeited (71,375) 91.54 Vested (1) (585,175) 85.35 Unvested at June 30, 2023 2,261,742 $ 95.51 (1) During the six months ended June 30, 2023, in accordance with our Nonqualified Deferred Compensation Plan, recipients elected to defer settlement of 2,925 shares of their vested restricted stock units and 132,518 shares were released from deferral. Employee Stock Purchase Plan During the six months ended June 30, 2023, 107,125 shares of common stock were purchased under the ESPP at a weighted-average price of $51.77 per share, resulting in cash proceeds of $5.5 million.

Revenue Recognition

Revenue Recognition	6 Months Ended
	Jun. 30, 2023
Revenue from Contract with Customer [Abstract]
Revenue Recognition	Revenue Recognition Disaggregation of Revenue Revenues by industry are derived from leading software providers. The following table presents our revenues disaggregated by industry (in thousands): Three months ended June 30, Six months ended June 30, 2023 2022 2023 2022 Industrials $ 23,273 $ 19,018 $ 45,133 $ 37,588 Diversified financials 22,566 17,265 43,989 34,392 Information technology 17,263 15,498 33,884 30,135 Banks 15,101 13,087 30,622 26,072 Consumer discretionary 14,933 12,628 29,309 24,846 Healthcare 13,432 11,832 26,400 23,457 Insurance 9,342 7,745 18,305 15,522 Energy 6,703 5,846 13,301 11,592 Real estate 6,479 5,928 13,165 12,004 Materials 5,668 5,159 11,539 10,833 Utilities 5,774 5,457 11,311 11,417 Public administration 4,527 3,794 8,868 7,196 Consumer staples 4,542 4,148 8,988 8,208 Other 5,419 4,144 10,397 7,961 Total revenues $ 155,022 $ 131,549 $ 305,211 $ 261,223 The following table presents our revenues disaggregated by type of good or service (in thousands): Three months ended June 30, Six months ended June 30, 2023 2022 2023 2022 Subscription and support $ 136,772 $ 113,353 $ 266,436 $ 220,473 XBRL professional services 14,431 13,517 31,164 31,210 Other services 3,819 4,679 7,611 9,540 Total revenues $ 155,022 $ 131,549 $ 305,211 $ 261,223 Deferred Revenue We recognized $122.5 million and $101.1 million of revenue during the three months ended June 30, 2023 and 2022, respectively, that was included in the deferred revenue balances at the beginning of the respective periods. We recognized $212.6 million and $173.2 million of revenue during the six months ended June 30, 2023 and 2022, respectively, that was included in the deferred revenue balances at the beginning of the respective periods. Transaction Price Allocated to the Remaining Performance Obligations

Net Loss Per Share

Net Loss Per Share	6 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Net Loss Per Share	Net Loss Per Share Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by giving effect to all potential shares of common stock, including convertible senior notes, outstanding stock options, stock related to unvested restricted stock units, and common stock issuable pursuant to the ESPP to the extent dilutive. Basic and diluted net loss per share was the same for each period presented, as the inclusion of all potential common shares outstanding would have been anti-dilutive. The net loss per share is allocated based on the participation rights of the Class A and Class B common shares as if the loss for the year has been distributed. As the liquidation and dividend rights are identical, the net loss is allocated on a proportionate basis. A reconciliation of the denominator used in the calculation of basic and diluted loss per share is as follows (in thousands, except share and per share data): Three months ended June 30, 2023 June 30, 2022 Class A Class B Class A Class B Numerator Net loss $ (19,421) $ (1,489) $ (26,736) $ (2,125) Denominator Weighted-average common shares outstanding - basic and diluted 50,164,380 3,845,583 48,959,887 3,890,583 Basic and diluted net loss per share $ (0.39) $ (0.39) $ (0.55) $ (0.55) Six months ended June 30, 2023 June 30, 2022 Class A Class B Class A Class B Numerator Net loss $ (62,253) $ (4,807) $ (43,802) $ (3,552) Denominator Weighted-average common shares outstanding - basic and diluted 49,990,734 3,860,252 48,768,827 3,955,224 Basic and diluted net loss per share $ (1.25) $ (1.25) $ (0.90) $ (0.90) The anti-dilutive securities excluded from the weighted-average shares used to calculate the diluted net loss per common share were as follows: As of June 30, 2023 June 30, 2022 Shares subject to outstanding common stock options 1,359,116 1,612,619 Shares subject to unvested restricted stock units and performance restricted stock units 2,261,742 1,977,282 Shares issuable pursuant to the ESPP 96,892 60,892

Intangible Assets and Goodwill

Intangible Assets and Goodwill	6 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	Intangible Assets and Goodwill The following table presents the components of net intangible assets (in thousands): As of June 30, 2023 As of December 31, 2022 Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Acquired technology 4.5 $ 15,851 $ (5,654) $ 10,197 $ 15,705 $ (3,849) $ 11,856 Acquired customer-related 10.0 15,244 (1,964) 13,280 14,969 (1,169) 13,800 Acquired trade names 3.0 2,164 (1,301) 863 2,151 (861) 1,290 Patents 10.0 3,035 (1,732) 1,303 2,916 (1,628) 1,288 Total 7.2 $ 36,294 $ (10,651) $ 25,643 $ 35,741 $ (7,507) $ 28,234 Amortization expense related to intangible assets was $1.5 million during the three months ended June 30, 2023 and 2022, and $3.1 million and $2.3 million for the six months ended June 30, 2023 and 2022, respectively. As of June 30, 2023, expected remaining amortization expense of intangible assets by fiscal year is as follows (in thousands): Remainder of 2023 $ 3,091 2024 5,446 2025 4,712 2026 3,401 2027 2,094 Thereafter 6,899 Total expected amortization expense $ 25,643 The changes in the carrying amount of goodwill were as follows (in thousands): December 31, 2022 $ 109,740 Foreign currency translation adjustments 1,414 June 30, 2023 $ 111,154

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2023	Jun. 30, 2022
Pay vs Performance Disclosure
Net loss	$ (20,910)	$ (46,150)	$ (28,861)	$ (18,493)	$ (67,060)	$ (47,354)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Organization and Significant _2

Organization and Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	The financial information presented in the accompanying unaudited condensed consolidated financial statements has been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) and in accordance with rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting. The condensed consolidated balance sheet data as of December 31, 2022 was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, consisting primarily of normal recurring accruals, necessary for a fair presentation of our financial position and results of operations. The operating results for the three and six months ended June 30, 2023 are not necessarily indicative of the results expected for the full year ending December 31, 2023.
Principles of Consolidation	All intercompany accounts and transactions have been eliminated in consolidation.
Use of Estimates	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. We base our estimates on historical experience and various other assumptions believed to be reasonable. These estimates include, but are not limited to, the allowance for doubtful accounts, the determination of the relative selling prices of our services, the measurement of material rights, health insurance claims incurred but not yet reported, valuation of available-for-sale marketable securities, useful lives of deferred contract costs, intangible assets and property and equipment, goodwill, income taxes, discount rates used in the valuation of right-of-use assets and lease liabilities, and certain assumptions used in the valuation of equity awards. While these estimates are based on our best knowledge of current events and actions that may affect us in the future, actual results may differ materially from these estimates.
Recently Adopted Accounting Pronouncements and New Accounting Pronouncements Not Yet Adopted	None.None.
Fair Value of Financial Instruments	Cash equivalents primarily consist of AAA-rated money market funds with overnight liquidity and no stated maturities. We classified cash equivalents as Level 1 due to the short-term nature of these instruments and measured the fair value based on quoted prices in active markets for identical assets. When available, our marketable securities are valued using quoted prices for identical instruments in active markets. If we are unable to value our marketable securities using quoted prices for identical instruments in active markets, we value our investments using broker reports that utilize quoted market prices for comparable instruments. We validate, on a sample basis, the derived prices provided by the brokers by comparing their assessment of the fair values of our investments against the fair values of the portfolio balances of another third-party professional pricing service.

Supplemental Consolidated Bal_2

Supplemental Consolidated Balance Sheet Information (Tables)	6 Months Ended
	Jun. 30, 2023
Payables and Accruals [Abstract]
Schedule of Accrued Expenses and Other Current Liabilities	Accrued expenses and other current liabilities consisted of the following (in thousands): As of June 30, 2023 As of December 31, 2022 Accrued vacation $ 16,196 $ 12,939 Accrued commissions 8,508 10,841 Accrued bonuses 14,668 5,597 Accrued payroll 4,190 5,318 Estimated health insurance claims 1,939 1,841 Accrued interest 1,455 1,455 ESPP employee contributions 7,075 5,661 Customer deposits 23,431 25,520 Operating lease liabilities 5,073 5,720 Accrued other liabilities 8,583 9,107 $ 91,118 $ 83,999

Cash Equivalents and Marketab_2

Cash Equivalents and Marketable Securities (Tables)	6 Months Ended
	Jun. 30, 2023
Investments, Debt and Equity Securities [Abstract]
Schedule of Marketable Securities	At June 30, 2023, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 130,774 $ — $ — $ 130,774 Commercial paper 78,820 — — 78,820 U.S. treasury debt securities 53,749 — (353) 53,396 U.S. government agency debt securities 22,088 — (58) 22,030 Corporate debt securities 115,026 23 (961) 114,088 Foreign government debt securities 996 — (18) 978 $ 401,453 $ 23 $ (1,390) $ 400,086 Included in cash and cash equivalents $ 132,774 $ — $ — $ 132,774 Included in marketable securities $ 268,679 $ 23 $ (1,390) $ 267,312 At December 31, 2022, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 182,878 $ — $ — $ 182,878 U.S. treasury debt securities 72,151 1 (899) 71,253 Corporate debt securities 120,081 62 (1,771) 118,372 Foreign government debt securities 993 — (23) 970 $ 376,103 $ 63 $ (2,693) $ 373,473 Included in cash and cash equivalents $ 182,878 $ — $ — $ 182,878 Included in marketable securities $ 193,225 $ 63 $ (2,693) $ 190,595
Schedule of Cash and Cash Equivalents	At June 30, 2023, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 130,774 $ — $ — $ 130,774 Commercial paper 78,820 — — 78,820 U.S. treasury debt securities 53,749 — (353) 53,396 U.S. government agency debt securities 22,088 — (58) 22,030 Corporate debt securities 115,026 23 (961) 114,088 Foreign government debt securities 996 — (18) 978 $ 401,453 $ 23 $ (1,390) $ 400,086 Included in cash and cash equivalents $ 132,774 $ — $ — $ 132,774 Included in marketable securities $ 268,679 $ 23 $ (1,390) $ 267,312 At December 31, 2022, cash equivalents and marketable securities consisted of the following (in thousands): Amortized Cost Unrealized Gains Unrealized Losses Aggregate Fair Value Money market funds $ 182,878 $ — $ — $ 182,878 U.S. treasury debt securities 72,151 1 (899) 71,253 Corporate debt securities 120,081 62 (1,771) 118,372 Foreign government debt securities 993 — (23) 970 $ 376,103 $ 63 $ (2,693) $ 373,473 Included in cash and cash equivalents $ 182,878 $ — $ — $ 182,878 Included in marketable securities $ 193,225 $ 63 $ (2,693) $ 190,595
Schedule of Investments Classified by Contractual Maturity Date	The contractual maturities of the investments classified as marketable securities are as follows (in thousands): As of June 30, 2023 Due within one year $ 204,212 Due in one to two years 63,100 $ 267,312
Schedule of Available-for-sale Securities, Continuous Unrealized Loss Position	The following table presents gross unrealized losses and fair values for those cash equivalents and marketable securities that were in an unrealized loss position as of June 30, 2023, aggregated by investment category and the length of time that individual securities have been in a continuous loss position (in thousands): As of June 30, 2023 Less than 12 months 12 months or greater Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. treasury debt securities $ 45,910 $ (291) $ 6,486 $ (62) U.S. government agency debt securities 22,030 (58) — — Corporate debt securities 73,616 (493) 33,255 (468) Foreign government debt securities — — 978 (18) Total $ 141,556 $ (842) $ 40,719 $ (548)

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Assets Measured on Recurring Basis	The following table presents information about our assets that are measured at fair value on a recurring basis using the above input categories (in thousands): Fair Value Measurements as of June 30, 2023 Fair Value Measurements as of December 31, 2022 Description Total Level 1 Level 2 Total Level 1 Level 2 Money market funds $ 130,774 $ 130,774 $ — $ 182,878 $ 182,878 $ — Commercial paper 78,820 — 78,820 — — — U.S. treasury debt securities 53,396 — 53,396 71,253 — 71,253 U.S. government agency debt securities 22,030 — 22,030 — — — Corporate debt securities 114,088 — 114,088 118,372 — 118,372 Foreign government debt securities 978 — 978 970 — 970 $ 400,086 $ 130,774 $ 269,312 $ 373,473 $ 182,878 $ 190,595 Included in cash and cash equivalents $ 132,774 $ 182,878 Included in marketable securities $ 267,312 $ 190,595

Convertible Senior Notes (Table

Convertible Senior Notes (Tables)	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Schedule of Convertible Debt	The net carrying amount of the Notes was as follows (in thousands): As of June 30, 2023 December 31, 2022 Principal $ 345,000 $ 345,000 Unamortized issuance costs (4,093) (4,743) Net carrying amount $ 340,907 $ 340,257 Interest expense related to the Notes was as follows (in thousands): Three months ended June 30, Six months ended June 30, 2023 2022 2023 2022 Contractual interest expense $ 970 $ 970 $ 1,940 $ 1,940 Amortization of issuance costs 325 324 650 648 Total interest expense $ 1,295 $ 1,294 $ 2,590 $ 2,588

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	6 Months Ended
	Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]
Schedule of Stock-based Compensation Expense	Stock-based compensation expense was recorded in the following cost and expense categories consistent with the respective employee or service provider’s related cash compensation (in thousands): Three months ended June 30, Six months ended June 30, 2023 2022 2023 2022 Cost of revenue Subscription and support $ 1,413 $ 912 $ 2,485 $ 1,702 Professional services 667 593 1,300 1,045 Operating expenses Research and development 4,825 3,148 9,522 5,873 Sales and marketing 6,703 5,646 13,661 9,731 General and administrative 7,002 8,148 31,684 15,405 Total $ 20,610 $ 18,447 $ 58,652 $ 33,756
Schedule of Stock-Option Activity	The following table summarizes the option activity under the Plans for the six months ended June 30, 2023: Options Weighted- Average Exercise Price Weighted- Average Remaining Contractual Term (Years) Outstanding at December 31, 2022 1,509,172 $ 14.57 3.2 Granted — — Forfeited (10) 13.60 Expired — — Exercised (150,046) 14.69 Outstanding at June 30, 2023 1,359,116 $ 14.56 2.7 Exercisable at June 30, 2023 1,359,116 $ 14.56 2.7
Schedule of Restricted Stock Units and Performance Restricted Stock Units Activity	The following table summarizes the restricted stock unit and performance restricted stock unit activity under the Plans for the six months ended June 30, 2023: Number of Shares Weighted- Average Grant Date Fair Value Unvested at December 31, 2022 1,921,927 $ 93.80 Granted 996,365 93.10 Forfeited (71,375) 91.54 Vested (1) (585,175) 85.35 Unvested at June 30, 2023 2,261,742 $ 95.51

Revenue Recognition (Tables)

Revenue Recognition (Tables)	6 Months Ended
	Jun. 30, 2023
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following table presents our revenues disaggregated by industry (in thousands): Three months ended June 30, Six months ended June 30, 2023 2022 2023 2022 Industrials $ 23,273 $ 19,018 $ 45,133 $ 37,588 Diversified financials 22,566 17,265 43,989 34,392 Information technology 17,263 15,498 33,884 30,135 Banks 15,101 13,087 30,622 26,072 Consumer discretionary 14,933 12,628 29,309 24,846 Healthcare 13,432 11,832 26,400 23,457 Insurance 9,342 7,745 18,305 15,522 Energy 6,703 5,846 13,301 11,592 Real estate 6,479 5,928 13,165 12,004 Materials 5,668 5,159 11,539 10,833 Utilities 5,774 5,457 11,311 11,417 Public administration 4,527 3,794 8,868 7,196 Consumer staples 4,542 4,148 8,988 8,208 Other 5,419 4,144 10,397 7,961 Total revenues $ 155,022 $ 131,549 $ 305,211 $ 261,223 The following table presents our revenues disaggregated by type of good or service (in thousands): Three months ended June 30, Six months ended June 30, 2023 2022 2023 2022 Subscription and support $ 136,772 $ 113,353 $ 266,436 $ 220,473 XBRL professional services 14,431 13,517 31,164 31,210 Other services 3,819 4,679 7,611 9,540 Total revenues $ 155,022 $ 131,549 $ 305,211 $ 261,223

Net Loss Per Share (Tables)

Net Loss Per Share (Tables)	6 Months Ended
	Jun. 30, 2023
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	A reconciliation of the denominator used in the calculation of basic and diluted loss per share is as follows (in thousands, except share and per share data): Three months ended June 30, 2023 June 30, 2022 Class A Class B Class A Class B Numerator Net loss $ (19,421) $ (1,489) $ (26,736) $ (2,125) Denominator Weighted-average common shares outstanding - basic and diluted 50,164,380 3,845,583 48,959,887 3,890,583 Basic and diluted net loss per share $ (0.39) $ (0.39) $ (0.55) $ (0.55) Six months ended June 30, 2023 June 30, 2022 Class A Class B Class A Class B Numerator Net loss $ (62,253) $ (4,807) $ (43,802) $ (3,552) Denominator Weighted-average common shares outstanding - basic and diluted 49,990,734 3,860,252 48,768,827 3,955,224 Basic and diluted net loss per share $ (1.25) $ (1.25) $ (0.90) $ (0.90)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The anti-dilutive securities excluded from the weighted-average shares used to calculate the diluted net loss per common share were as follows: As of June 30, 2023 June 30, 2022 Shares subject to outstanding common stock options 1,359,116 1,612,619 Shares subject to unvested restricted stock units and performance restricted stock units 2,261,742 1,977,282 Shares issuable pursuant to the ESPP 96,892 60,892

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	6 Months Ended
	Jun. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Summary of Intangible Assets	The following table presents the components of net intangible assets (in thousands): As of June 30, 2023 As of December 31, 2022 Weighted Average Useful Life (Years) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Gross Carrying Amount Accumulated Amortization Net Carrying Amount Acquired technology 4.5 $ 15,851 $ (5,654) $ 10,197 $ 15,705 $ (3,849) $ 11,856 Acquired customer-related 10.0 15,244 (1,964) 13,280 14,969 (1,169) 13,800 Acquired trade names 3.0 2,164 (1,301) 863 2,151 (861) 1,290 Patents 10.0 3,035 (1,732) 1,303 2,916 (1,628) 1,288 Total 7.2 $ 36,294 $ (10,651) $ 25,643 $ 35,741 $ (7,507) $ 28,234
Schedule of Expected Amortization Expense of Intangible Assets	As of June 30, 2023, expected remaining amortization expense of intangible assets by fiscal year is as follows (in thousands): Remainder of 2023 $ 3,091 2024 5,446 2025 4,712 2026 3,401 2027 2,094 Thereafter 6,899 Total expected amortization expense $ 25,643
Schedule of the Changes in the Carrying Amount of Goodwill	The changes in the carrying amount of goodwill were as follows (in thousands): December 31, 2022 $ 109,740 Foreign currency translation adjustments 1,414 June 30, 2023 $ 111,154

Supplemental Consolidated Bal_3

Supplemental Consolidated Balance Sheet Information (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Accrued Liabilities and Other Liabilities [Abstract]
Accrued vacation	$ 16,196	$ 12,939
Accrued commissions	8,508	10,841
Accrued bonuses	14,668	5,597
Accrued payroll	4,190	5,318
Estimated health insurance claims	1,939	1,841
Accrued interest	1,455	1,455
ESPP employee contributions	7,075	5,661
Customer deposits	23,431	25,520
Operating lease liabilities	5,073	5,720
Accrued other liabilities	8,583	9,107
Accrued expenses and other current liabilities	$ 91,118	$ 83,999

Cash Equivalents and Marketab_3

Cash Equivalents and Marketable Securities - Schedule of Marketable Securities (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents, amortized cost	$ 198,939	$ 240,197
Debt Securities, Available-for-sale [Line Items]
Marketable securities, amortized cost	268,679	193,225
Marketable securities, unrealized gains	23	63
Marketable securities, unrealized losses	(1,390)	(2,693)
Marketable securities, aggregate fair value	267,312	190,595
Cash and cash equivalents and available-for-sale securities, amortized cost	401,453	376,103
Cash and cash equivalents and marketable securities, aggregate fair value	400,086	373,473
Commercial paper
Debt Securities, Available-for-sale [Line Items]
Marketable securities, amortized cost	78,820
Marketable securities, unrealized gains	0
Marketable securities, unrealized losses	0
Marketable securities, aggregate fair value	78,820
U.S. treasury debt securities
Debt Securities, Available-for-sale [Line Items]
Marketable securities, unrealized gains	0	1
Marketable securities, unrealized losses	(353)	(899)
Cash and cash equivalents and available-for-sale securities, amortized cost	53,749	72,151
Cash and cash equivalents and marketable securities, aggregate fair value	53,396	71,253
U.S. government agency debt securities
Debt Securities, Available-for-sale [Line Items]
Marketable securities, amortized cost	22,088
Marketable securities, unrealized gains	0
Marketable securities, unrealized losses	(58)
Marketable securities, aggregate fair value	22,030
Corporate debt securities
Debt Securities, Available-for-sale [Line Items]
Marketable securities, amortized cost	115,026	120,081
Marketable securities, unrealized gains	23	62
Marketable securities, unrealized losses	(961)	(1,771)
Marketable securities, aggregate fair value	114,088	118,372
Foreign government debt securities
Debt Securities, Available-for-sale [Line Items]
Marketable securities, amortized cost	996	993
Marketable securities, unrealized gains	0	0
Marketable securities, unrealized losses	(18)	(23)
Marketable securities, aggregate fair value	978	970
Money market funds
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents, amortized cost	130,774	182,878
Cash and cash equivalents, aggregate fair value	130,774	182,878
Cash Equivalents
Cash and Cash Equivalents [Line Items]
Cash and cash equivalents, amortized cost	132,774	182,878
Cash and cash equivalents, aggregate fair value	$ 132,774	$ 182,878

Cash Equivalents and Marketab_4

Cash Equivalents and Marketable Securities - Schedule of Contractual Maturities (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Investments, Debt and Equity Securities [Abstract]
Due within one year	$ 204,212
Due in one to two years	63,100
Marketable securities	$ 267,312	$ 190,595

Cash Equivalents and Marketab_5

Cash Equivalents and Marketable Securities - Continuous Unrealized Loss Position (Details) $ in Thousands	Jun. 30, 2023 USD ($)
Fair Value
Less than 12 months	$ 141,556
12 months or greater	40,719
Unrealized Loss
Less than 12 months	(842)
12 months or greater	(548)
U.S. treasury debt securities
Fair Value
Less than 12 months	45,910
12 months or greater	6,486
Unrealized Loss
Less than 12 months	(291)
12 months or greater	(62)
U.S. government agency debt securities
Fair Value
Less than 12 months	22,030
12 months or greater	0
Unrealized Loss
Less than 12 months	(58)
12 months or greater	0
Corporate debt securities
Fair Value
Less than 12 months	73,616
12 months or greater	33,255
Unrealized Loss
Less than 12 months	(493)
12 months or greater	(468)
Foreign government debt securities
Fair Value
Less than 12 months	0
12 months or greater	978
Unrealized Loss
Less than 12 months	0
12 months or greater	$ (18)

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	$ 267,312	$ 190,595
Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	78,820
U.S. government agency debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	22,030
Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	114,088	118,372
Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	978	970
Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	130,774	182,878
Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	132,774	182,878
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value of convertible debt	484,700
Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	267,312	190,595
Total assets measured at fair value	400,086	373,473
Recurring | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	78,820	0
Recurring | U.S. treasury debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	53,396	71,253
Recurring | U.S. government agency debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	22,030	0
Recurring | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	114,088	118,372
Recurring | Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	978	970
Recurring | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	130,774	182,878
Recurring | Cash Equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	132,774	182,878
Recurring | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	130,774	182,878
Recurring | Level 1 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Recurring | Level 1 | U.S. treasury debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Recurring | Level 1 | U.S. government agency debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Recurring | Level 1 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Recurring | Level 1 | Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Recurring | Level 1 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	130,774	182,878
Recurring | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets measured at fair value	269,312	190,595
Recurring | Level 2 | Commercial paper
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	78,820	0
Recurring | Level 2 | U.S. treasury debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	53,396	71,253
Recurring | Level 2 | U.S. government agency debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	22,030	0
Recurring | Level 2 | Corporate debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	114,088	118,372
Recurring | Level 2 | Foreign government debt securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	978	970
Recurring | Level 2 | Money market funds
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	$ 0	$ 0

Convertible Senior Notes - Narr

Convertible Senior Notes - Narrative (Details)	1 Months Ended	6 Months Ended
	Aug. 31, 2019 USD ($) day $ / shares	Jun. 30, 2023 USD ($) $ / shares	Dec. 31, 2022 $ / shares
Class A Common Stock
Debt Instrument [Line Items]
Common stock, par value (in dollars per share) | $ / shares	$ 0.001	$ 0.001	$ 0.001
Convertible debt | 1.125% Convertible Senior Notes Due 2026
Debt Instrument [Line Items]
Face amount of debt issued | $	$ 345,000,000
Stated interest percentage	1.125%
Proceeds from the issuance of convertible senior notes, net of issuance costs | $	$ 335,900,000
Conversion ratio	0.0124756
Conversion price (in dollars per share) | $ / shares	$ 80.16
Threshold number of trading days (day)	20
Threshold number of consecutive trading days (day)	30
Threshold percentage of stock price trigger	130%
Redemption price, percentage	100%
Effective interest percentage		1.50%
If-converted value in excess of principal | $		$ 92,500,000
Remaining life of debt instrument		3 years 2 months 12 days
Convertible debt | 1.125% Convertible Senior Notes Due 2026 | Debt Conversion Terms, One
Debt Instrument [Line Items]
Threshold number of trading days (day)	20
Threshold number of consecutive trading days (day)	30
Threshold percentage of stock price trigger	130%
Convertible debt | 1.125% Convertible Senior Notes Due 2026 | Debt Conversion Terms, Two
Debt Instrument [Line Items]
Threshold number of trading days (day)	5
Threshold number of consecutive trading days (day)	10
Threshold percentage of stock trading price	98%
Convertible debt | Over-allotment option
Debt Instrument [Line Items]
Face amount of debt issued | $	$ 45,000,000

Convertible Senior Notes - Summ

Convertible Senior Notes - Summary of Convertible Debt (Details) - 1.125% Convertible Senior Notes Due 2026 - Convertible debt - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Principal	$ 345,000	$ 345,000
Unamortized issuance costs	(4,093)	(4,743)
Net carrying amount	$ 340,907	$ 340,257

Convertible Senior Notes - Su_2

Convertible Senior Notes - Summary of Interest Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Debt Disclosure [Abstract]
Contractual interest expense	$ 970	$ 970	$ 1,940	$ 1,940
Amortization of issuance costs	325	324	650	648
Total interest expense	$ 1,295	$ 1,294	$ 2,590	$ 2,588

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 20,610	$ 18,447	$ 58,652	$ 33,756
Former executives who retired
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense			18,100
Research and development
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	4,825	3,148	9,522	5,873
Sales and marketing
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	6,703	5,646	13,661	9,731
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	7,002	8,148	31,684	15,405
Subscription and support | Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	1,413	912	2,485	1,702
Professional services | Cost of revenue
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
Share-based compensation expense	$ 667	$ 593	$ 1,300	$ 1,045

Stock-Based Compensation - St_2

Stock-Based Compensation - Stock Options (Details)	6 Months Ended	12 Months Ended
	Jun. 30, 2023 $ / shares shares	Dec. 31, 2022 $ / shares shares
Options (in shares):
Outstanding beginning of the period (in shares) | shares	1,509,172
Granted (in shares) | shares	0
Forfeited (in shares) | shares	(10)
Expired (in shares) | shares	0
Exercised (in shares) | shares	(150,046)
Outstanding end of the period (in shares) | shares	1,359,116	1,509,172
Exercisable (in shares) | shares	1,359,116
Weighted-Average Exercise Price (in dollars per share):
Outstanding beginning of the period (in dollars per share) | $ / shares	$ 14.57
Granted (in dollars per share) | $ / shares	0
Forfeited (in dollars per share) | $ / shares	13.60
Expired (in dollars per share) | $ / shares	0
Exercised (in dollars per share) | $ / shares	14.69
Outstanding end of the period (in dollars per share) | $ / shares	14.56	$ 14.57
Exercisable (in dollars per share) | $ / shares	$ 14.56
Outstanding, weighted-average remaining contractual term (years)	2 years 8 months 12 days	3 years 2 months 12 days
Exercisable, weighted-average remaining contractual term (years)	2 years 8 months 12 days

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock Units and Performance Restricted Stock Units (Details)	6 Months Ended
	Jun. 30, 2023 $ / shares shares
Shares subject to unvested restricted stock units and performance restricted stock units
Number of Shares (in shares)
Unvested at beginning of period (in shares)	1,921,927
Granted (in shares)	996,365
Forfeited (in shares)	(71,375)
Vested (in shares)	(585,175)
Unvested at end of period (in shares)	2,261,742
Weighted- Average Grant Date Fair Value (in dollars per share)
Unvested at beginning of period (in dollars per share) | $ / shares	$ 93.80
Granted (in dollars per share) | $ / shares	93.10
Forfeited (in dollars per share) | $ / shares	91.54
Vested (in dollars per share) | $ / shares	85.35
Unvested at end of period (in dollars per share) | $ / shares	$ 95.51
Restricted stock units
Weighted- Average Grant Date Fair Value (in dollars per share)
Number of vested shares recipient elected to defer settlement (in shares)	2,925
Number of vested shares recipients elected to defer settlement, released during period (in shares)	132,518

Stock-Based Compensation - Empl

Stock-Based Compensation - Employee Stock Purchase Plan (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from shares issued in connection with employee stock purchase plan	$ 0	$ 0	$ 5,546	$ 5,218
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense	$ 200		$ 200
Unrecognized compensation expense, period for recognition (years)			14 days
Class A Common Stock | Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares issued during period (in shares)			107,125
Shares issued during period, weighted average price per share (in dollars per share)			$ 51.77
Proceeds from shares issued in connection with employee stock purchase plan			$ 5,500

Revenue Recognition - Disaggreg

Revenue Recognition - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Disaggregation of Revenue [Line Items]
Total revenue	$ 155,022	$ 131,549	$ 305,211	$ 261,223
Subscription and support
Disaggregation of Revenue [Line Items]
Total revenue	136,772	113,353	266,436	220,473
XBRL professional services
Disaggregation of Revenue [Line Items]
Total revenue	14,431	13,517	31,164	31,210
Other services
Disaggregation of Revenue [Line Items]
Total revenue	3,819	4,679	7,611	9,540
Industrials
Disaggregation of Revenue [Line Items]
Total revenue	23,273	19,018	45,133	37,588
Diversified financials
Disaggregation of Revenue [Line Items]
Total revenue	22,566	17,265	43,989	34,392
Information technology
Disaggregation of Revenue [Line Items]
Total revenue	17,263	15,498	33,884	30,135
Banks
Disaggregation of Revenue [Line Items]
Total revenue	15,101	13,087	30,622	26,072
Consumer discretionary
Disaggregation of Revenue [Line Items]
Total revenue	14,933	12,628	29,309	24,846
Healthcare
Disaggregation of Revenue [Line Items]
Total revenue	13,432	11,832	26,400	23,457
Insurance
Disaggregation of Revenue [Line Items]
Total revenue	9,342	7,745	18,305	15,522
Energy
Disaggregation of Revenue [Line Items]
Total revenue	6,703	5,846	13,301	11,592
Real estate
Disaggregation of Revenue [Line Items]
Total revenue	6,479	5,928	13,165	12,004
Materials
Disaggregation of Revenue [Line Items]
Total revenue	5,668	5,159	11,539	10,833
Utilities
Disaggregation of Revenue [Line Items]
Total revenue	5,774	5,457	11,311	11,417
Public administration
Disaggregation of Revenue [Line Items]
Total revenue	4,527	3,794	8,988	8,208
Consumer staples
Disaggregation of Revenue [Line Items]
Total revenue	4,542	4,148	8,868	7,196
Other
Disaggregation of Revenue [Line Items]
Total revenue	$ 5,419	$ 4,144	$ 10,397	$ 7,961

Revenue Recognition - Deferred

Revenue Recognition - Deferred Revenue and Transaction Price Allocated to the Remaining Performance Obligations (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenue from Contract with Customer [Abstract]
Deferred revenue recognized	$ 122.5	$ 101.1	$ 212.6	$ 173.2
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized	817.4		817.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-07-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue expected to be recognized	$ 454.7		$ 454.7
Expected period of recognition	12 months		12 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-07-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Expected period of recognition	24 months		24 months

Net Loss Per Share - Earnings P

Net Loss Per Share - Earnings Per Share Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Denominator
Weighted-average common shares outstanding - basic (in shares)	54,009,963	52,850,470	53,850,986	52,724,051
Weighted-average common shares outstanding - diluted (in shares)	54,009,963	52,850,470	53,850,986	52,724,051
Basic net loss per share (in dollars per share)	$ (0.39)	$ (0.55)	$ (1.25)	$ (0.90)
Diluted net loss per share (in dollars per share)	$ (0.39)	$ (0.55)	$ (1.25)	$ (0.90)
Class A Common Stock
Numerator
Net loss, basic	$ (19,421)	$ (26,736)	$ (62,253)	$ (43,802)
Net loss, diluted	$ (19,421)	$ (26,736)	$ (62,253)	$ (43,802)
Denominator
Weighted-average common shares outstanding - basic (in shares)	50,164,380	48,959,887	49,990,734	48,768,827
Weighted-average common shares outstanding - diluted (in shares)	50,164,380	48,959,887	49,990,734	48,768,827
Basic net loss per share (in dollars per share)	$ (0.39)	$ (0.55)	$ (1.25)	$ (0.90)
Diluted net loss per share (in dollars per share)	$ (0.39)	$ (0.55)	$ (1.25)	$ (0.90)
Class B Common Stock
Numerator
Net loss, basic	$ (1,489)	$ (2,125)	$ (4,807)	$ (3,552)
Net loss, diluted	$ (1,489)	$ (2,125)	$ (4,807)	$ (3,552)
Denominator
Weighted-average common shares outstanding - basic (in shares)	3,845,583	3,890,583	3,860,252	3,955,224
Weighted-average common shares outstanding - diluted (in shares)	3,845,583	3,890,583	3,860,252	3,955,224
Basic net loss per share (in dollars per share)	$ (0.39)	$ (0.55)	$ (1.25)	$ (0.90)
Diluted net loss per share (in dollars per share)	$ (0.39)	$ (0.55)	$ (1.25)	$ (0.90)

Net Loss Per Share - Antidiluti

Net Loss Per Share - Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Class A Common Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	4,300,000	4,300,000
Shares subject to outstanding common stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	1,359,116	1,612,619
Shares subject to unvested restricted stock units and performance restricted stock units
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	2,261,742	1,977,282
Shares issuable pursuant to the ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share (in shares)	96,892	60,892

Intangible Assets and Goodwil_2

Intangible Assets and Goodwill - Intangible Asset Components (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	7 years 2 months 12 days
Gross Carrying Amount	$ 36,294	$ 35,741
Accumulated Amortization	(10,651)	(7,507)
Net Carrying Amount	$ 25,643	28,234
Acquired technology
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	4 years 6 months
Gross Carrying Amount	$ 15,851	15,705
Accumulated Amortization	(5,654)	(3,849)
Net Carrying Amount	$ 10,197	11,856
Acquired customer-related
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	10 years
Gross Carrying Amount	$ 15,244	14,969
Accumulated Amortization	(1,964)	(1,169)
Net Carrying Amount	$ 13,280	13,800
Acquired trade names
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	3 years
Gross Carrying Amount	$ 2,164	2,151
Accumulated Amortization	(1,301)	(861)
Net Carrying Amount	$ 863	1,290
Patents
Finite-Lived Intangible Assets [Line Items]
Weighted Average Useful Life (Years)	10 years
Gross Carrying Amount	$ 3,035	2,916
Accumulated Amortization	(1,732)	(1,628)
Net Carrying Amount	$ 1,303	$ 1,288

Intangible Assets and Goodwil_3

Intangible Assets and Goodwill - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense related to intangible assets	$ 1.5	$ 1.5	$ 3.1	$ 2.3

Intangible Assets and Goodwil_4

Intangible Assets and Goodwill - Amortization of Intangible Assets by Fiscal Year (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Remainder of 2023	$ 3,091
2024	5,446
2025	4,712
2026	3,401
2027	2,094
Thereafter	6,899
Net Carrying Amount	$ 25,643	$ 28,234

Intangible Assets and Goodwil_5

Intangible Assets and Goodwill - Goodwill Activity (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2023 USD ($)
Goodwill [Roll Forward]
Goodwill, beginning balance	$ 109,740
Foreign currency translation adjustments	1,414
Goodwill, ending balance	$ 111,154

Uncategorized Items - wk-202306

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2020-06 [Member]